NCT03426891 2025-10-06
Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
Clinical Trials
7 trialsNCT06485947 2025-07-08
DBPilot
Princess Maxima Center for Pediatric Oncology
Phase 1 Recruiting
NCT06283927 2024-02-28
RECSUR
Erasmus Medical Center
Recruiting
NCT03458455 2023-11-01
TREATMENT
Oslo University Hospital
Unknown
NCT04650490 2023-03-02
STICk-IM-NSCLC
Duke University
Phase 2 Withdrawn
NCT04291092 2021-09-10
Camrelizumab Combined With Local Treatment in NSCLC Patients With BM
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT00186862 2008-06-03
Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma
St. Jude Children's Research Hospital
Phase 1 Completed